Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss
Balance at beginning of period at Oct. 31, 2017	$ 617,092	$ 106,883	$ 534,329	$ (24,120)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(21,425)		(21,425)
Issuance of shares for stock options exercised and restricted stock units vested	2,999	507	2,492
Stock-based compensation expense	3,124		3,124
Contribution of stock to a deferred compensation trust	1,437		1,437
Purchase of common stock	(53,143)	(955)	(52,188)
Other comprehensive (loss)/Income	8,093			8,093
Net earnings	22,604		22,604
Balance at end of period at Feb. 02, 2018	580,781	106,435	490,373	(16,027)
Balance at beginning of period at Oct. 31, 2018	668,916	105,601	587,252	(23,937)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(23,923)		(23,923)
Issuance of shares for stock options exercised and restricted stock units vested	6,165	538	5,627
Stock-based compensation expense	3,924		3,924
Contribution of stock to a deferred compensation trust	1,404		1,404
Purchase of common stock	(21,915)	(392)	(21,523)
Other comprehensive (loss)/Income	(578)			(578)
Net earnings	59,540		59,540
Balance at end of period at Feb. 01, 2019	$ 694,397	$ 105,747	$ 613,165	$ (24,515)